 NASHVILLE, Tenn., April 15, 2021 GLOBE NEWSWIRE -- Harrow Health, Inc. NASDAQ: HROW Harrow Health or the Company, an ophthalmic-focused healthcare company, today announced the pricing of its underwritten registered public offering of 50 million aggregate principal amount of 8.625 senior notes due 2026 the Notes. The Company has granted the underwriters a 30-day option to purchase an additional 5.0 million aggregate principal amount of senior notes in connection with the offering. The offering is expected to close on April 20, 2021, subject to customary closing conditions. 